Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001209191-23-007775 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-08 | 2023-02-06 | KPTI | Mason Michael | EVP, CFO, Treas | S - Sale | $3.40 | -4,141 | 164.4K | -2% | -$14.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | S | D | 4,141 | $3.40 | 164,368 | D | — | — |